In recent studies, a new composite index named HALP, calculated as hemoglobin (g/L) × albumin (g/L) × lymphocyte (/L)/platelet (/L), was reported to be related to survival in gastric cancer, colorectal cancer, bladder cancer, and renal cancer patients [15,46,47,48,55]. The gene discussed is ALB; the disease is gastric cancer.